Drug overdoses surged during the pandemic. Providers are thinking outside the box to combat the opioid crisis

Tabula Rasa’s, Robert L. Alesiani, PharmD, BCGP, Chief Pharmacist and Chief Pharmacotherapy Officer is quoted in Fierce Healthcare. Alesiani discusses how MedWise^® was created to monitor patients for adverse drug reactions (ADEs) and take into account patients’ genomic background to determine whether their body produces particular metabolic enzymes.